Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other financing activities Other financing activities Preferred Shares Repurchased Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Lisata Therapeutics (LSTA) Net Cash Flow (2016 - 2025)

Lisata Therapeutics filings provide 13 years of Net Cash Flow readings, the most recent being -$3.0 million for Q4 2025.

For the quarter ending Q4 2025, Net Cash Flow rose 5.9% year-over-year to -$3.0 million, compared with a TTM value of -$264000.0 through Dec 2025, up 95.83%, and an annual FY2025 reading of -$264000.0, up 95.83% over the prior year.
Net Cash Flow hit -$3.0 million in Q4 2025 for Lisata Therapeutics, down from $2.2 million in the prior quarter.
The five-year high for Net Cash Flow was $8.7 million in Q3 2023, with the low at -$9.8 million in Q4 2023.
Median Net Cash Flow over the past 3 years was -$3.1 million (2024), compared with a mean of -$1.3 million.
The sharpest move saw Net Cash Flow crashed 201.85% in 2024, then surged 646.52% in 2025.
Year by year, Net Cash Flow stood at -$9.8 million in 2023, then surged by 66.85% to -$3.2 million in 2024, then increased by 5.9% to -$3.0 million in 2025.
According to Business Quant data, Net Cash Flow over the past three periods came in at -$3.0 million, $2.2 million, and -$3.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.